Talk:Marex (British company)

Requested move
MAREX Financial Limited → Marex Spectron – Marex Financial Limited and Spectron Group Limited are now operating and trading under the one brand Marex Spectron. The website for Marex Financial now redirects to Marex Spectron, therefore the page title should be changed to reflect the new situation. 05:06, 16 October 2011 (UTC)


 * Moved Noncontroversial move. Alpha_Quadrant    (talk)  03:39, 23 October 2011 (UTC)

Requested move 11 May 2021

 * The following is a closed discussion of a requested move. Please do not modify it. Subsequent comments should be made in a new section on the talk page. Editors desiring to contest the closing decision should consider a move review after discussing it on the closer's talk page. No further edits should be made to this discussion. 

The result of the move request was: Consensus to move the company to Marex (British company), as the company did change its name to Marex, however, there is not consensus that the company is the primary topic of Marex. (t &#183; c)  buidhe  00:21, 26 May 2021 (UTC)

– Marex Spectron is now operating and trading under the brand Marex. The website for Marex Spectrum now redirects to Marex, therefore the page title should be changed to reflect the new situation. the Marex page is being used to forward to the unrelated Terbutaline page and we request priority to use this page BCOMMS107 (talk) 08:47, 11 May 2021 (UTC) —Relisting. ~ Aseleste  (t, e &#124; c, l) 12:31, 18 May 2021 (UTC) PAGE ]]) 18:23, 11 May 2021 (UTC)
 * Marex Spectron → Marex
 * Marex → Marex (disambiguation)
 * This is a contested technical request (permalink). --Ahecht ([[User talk:Ahecht|TALK
 * Note: Marex now titles a page with significant content and so it is ineligible to be a target "new" title unless it is also proposed to be renamed. This request has been altered to reflect that fact.  P.I. Ellsworth   ed.  put'r there 17:47, 18 May 2021 (UTC)

PAGE ]]) 13:29, 11 May 2021 (UTC) PAGE ]]) 19:48, 18 May 2021 (UTC)
 * Terbutaline is sold under the brand name Marex in India, and the Terabutaline page gets 6 times the pageviews that Marex Spectron does. This should probably be discussed before moving. --Ahecht ([[User talk:Ahecht|TALK
 * Marex (formerly Marex Spectron) recently announced that it plans to list on the London Stock Exchange and will become a listed entity, which will likely drive heavy amount of traffic from shareholders. — Preceding unsigned comment added by BCOMMS107 (talk • contribs) 10:28, 17 May 2021 (UTC)
 * Oppose no evidence that this company would become PT by either criteria. Not even for (company) given the cluster of Florida companies name Marex and MarEx which may or may not be related to each other. In ictu oculi (talk) 15:07, 18 May 2021 (UTC)
 * However a GBook GNews search also indicates that the brand probably isn't a primary and case for a primary redirect is weak. Converting without prejudice to a dab. do you want to make a case that the pharma brand passes PT? In ictu oculi (talk) 15:10, 18 May 2021 (UTC)
 * I honestly don't know enough about Indian sources to judge whether the drug name is primary. I moved the discussion here from WP:RM/TR only because there didn't seem to be a clear case that this was a non-controversial move. --Ahecht ([[User talk:Ahecht|TALK


 * Support move to Marex (British company), with Marex being a dab page. 162 etc. (talk) 23:16, 18 May 2021 (UTC)
 * Support this alternative. No evidence that this company is or will become PT of Marex. Andrewa (talk) 13:01, 25 May 2021 (UTC)

Article updates
Hi, my name is Nicola, I am an employee at Marex. I wanted to approach the Wikipedia community to request a number of factual updates to the page. As an employee, I’m keen not to make the changes myself but work with a neutral editor. I have included the changes in a draft updated article below.

The changes focus on updates to company leadership and notable acquisitions as well as the company filing for an IPO.

Please do let me know of any questions or feedback. I look forward to collaborating with the Wikipedia community on this article. NicolaRatchford (talk) 09:43, 16 April 2024 (UTC)

Marex is a UK-based financial services company. The company's clients are predominantly commodity producers and consumers, banks, hedge funds, asset managers, broking houses, commodity trading advisors and professional traders. Marex currently has over 1,800 employees and 36 offices across Europe, USA and APAC.

History
Marex Financial started in 2005 as an independent derivatives and forex broker providing trading in commodities, financial futures, options and foreign exchange, established by the Marathon Special Opportunity Master Fund Limited which is managed by Marathon Asset Management after its former parent REFCo collapsed in 2005.

In February 2010, hedge fund JRJ Group took a 74% stake and executive control appointing a number of former Lehman Brothers bankers to its board to help expand business.

In May 2011, Marex Financial completed its acquisition of Spectron Group, a broker of wholesale energy and other commodity products when the company was renamed Marex Spectron International Limited. On April 1, 2021, the company changed its name to Marex.

Timeline (as Marex Spectron)
In July 2011, Marex Spectron acquired the Global Markets Division of Eden Financial, adding non-derivative products as well as European cash equities and fixed income to its range of services.

In May 2012, Marex Spectron acquired the Pro-Trader division of Schneider Trading Associates (STA), a provider of professional trader services.

In May 2016, the firm established Nanolytics Capital Partners, a business focused on developing alternative investment products based on Marex Spectron's Nanolytics models.

In July 2017, the group launched Marex Solutions, a division aimed at providing tailored hedging to commodity clients looking to manage commodity price risk across agricultural, energy, metals & FX markets.

Marex Spectron Group posted 2015 operating profit of $23 million, a 53 percent jump on the previous year. EBITDA increased to $31 million from $25 million in 2014.

Marex Spectron Group's net revenue for 2017 was $245.6 million, up $2.5 million from 2016. Pre-tax profits for 2017 were $25.4 million, down from $27.0 million in 2016, while adjusted EBITDA were a record $39.6 million, 6.7% higher than 2016.

In December 2018, Marex Spectron announced its acquisition of the customer business of Rosenthal Collins Group LLC, an independent futures commission merchant (FCM) based at Chicago.

In January 2019, Marex Spectron announced that it had acquired London-based trading firm CSC Commodities from BGC European Holdings.

In December 2019, the Group announced it had acquired London-based Marquee Oil, a physical oil broker.

In March 2020 the Group acquired Tangent Trading, a scrap metal trading firm.

Marex Spectron Group reported record results for 2019 with gross revenues up 43% to $554.9 million and net revenues up 19% to $349.9 million.

In November 2020, Marex Spectron acquired XFA, an exchange traded derivatives (ETD) execution broker, which is headquartered in Chicago and offices in New York and San Francisco.

In March 2021, Marex Spectron changed its name to Marex.

Timeline (as Marex)
In April 2021, Marex Group plc released record results, with an 37% increase in gross revenues to $762.4 million and net revenues up 18% to $414.7 million.

In April 2022, Marex Group plc released its latest set of record results, with net revenue up 31% to $543 million with strong performance across all segments, particularly Market Making and Execution and Clearing, combined with significant contribution from Solutions, which delivered >100% increase in net revenues. Adjusted Operating PBT was up 29% to $79.6 million driven primarily by strong organic growth. Eight consecutive years of growth and 26% Adjusted Operating PBT CAGR since 2014. Marex Group also increased client assets by 74% to $5.4 billion (2020: $3.1 billion).

On 1 August 2022 Marex announced it had agreed to acquire ED&F Man Capital Markets, the financial services division of ED&F Man Group.

In August 2023, Marex acquired Eagle Commodities, a boutique provider of crude oil and refined product options and environmental products, based in London and New York.

In December 2023, Marex completed the acquisition of TD Cowen’s prime brokerage and outsourced trading business. The business sits within Marex Capital Markets, which was formed in 2022 following its acquisition of ED&F Man Capital Markets.

IPO filing & 2023 FY earnings
In March 2024, Marex publicly filed for an initial public offering on the Nasdaq Exchange. As part of the filing, Marex announced that it had reported a 75% jump in annual revenue in 2023 to $1.24bn from $711m a year earlier. Marex's profit after tax for the same period jumped to $141 million, or $1.09 per share, from $98.2 million, or 80 cents a share, a year earlier. Marex grew active clients to over 4000 in 2023, from nearly 1800 in 2018. The business now employs roughly 2000 people in more than 35 global offices as of December 31, 2023.

Corporate operations
Headquartered in London, Marex has offices in Sydney, Hong Kong, Dubai, Singapore, Dublin, Frankfurt, Paris, Versailles, Oslo, Rotterdam and in North America, Chicago, Schaumburg IL, New York, Stamford, Clark NJ, Houston, Des Moines, San Francisco, Minneapolis, Montreal and Calgary.

Memberships
A member of the London Metal Exchange (Category-1),the CME Group exchanges, ICE US, NYSE Liffe, ICE Futures and Eurex, Marex Spectron subscribes to the Futures and Options Association and is regulated by the UK's Financial Conduct Authority.

In October 2023, Marex became a trading and clearing member of Singapore Exchange Group (SGX). The business also joined the Australian Securities Exchange (ASX), as a futures clearing and trading participant.